Male Pelvic Health: A Urological Call to Arms

Journal of Urology

Volumn 176, Issue 6, 2006, Pages 2351-2352

  Kaplan, Steven A ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC GMP; PHOSPHODIESTERASE V INHIBITOR; TESTOSTERONE;

CORPUS CAVERNOSUM; DETRUSOR MUSCLE; DYSLIPIDEMIA; EDITORIAL; ERECTILE DYSFUNCTION; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSTATE EPITHELIUM; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SMOOTH MUSCLE; TESTOSTERONE BLOOD LEVEL; URINARY TRACT INFECTION; WAIST CIRCUMFERENCE;

COMORBIDITY; DIABETES MELLITUS; HUMANS; IMPOTENCE; MALE; METABOLIC SYNDROME X; URINATION DISORDERS;

EID: 33750524002     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.125     Document Type: Editorial

References (10)

1. Rosen R., Altwein J., Boyle P., Kirby R.S., Lukacs B., Meuleman E., et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44 (2003) 637
2. McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 97 suppl (2006) 23
3. McVary K.T., Camps J., Henry G.D., Conner S.D., Tseng L.-J., and Van Den Ende G. Sildenafil improves erectile function and urinary symptoms in men with erectile dysfunction and concomitant lower urinary tract symptoms. abstract 1637. J Urol 175 suppl (2006) 527
4. Kaplan S., Gonzalez R., Ogiste J., and Te A. Combination of an alpha blocker, alfuzosin SR and a PDE-5 inhibitor, sildenafil citrate is superior to monotherapy in treating lower urinary tract symptoms (LUTS) and sexual dysfunction. J Urol 175 suppl (2006) 528 abstract 1638
5. Elhilali M., Emberton M., Matzkin H., Harving N., van Moorselaar J., Alcaraz A., et al. Long-term safety and improvement on LUTS, quality of life and sexual function with alfuzosin 10mg once daily: a 3-year experience in BPH patients in real life practice. J Urol 175 suppl (2006) 529 abstract 1643
6. Parsons J.K., Carter H.B., Partin A.W., Windham B.G., Metter E.J., Ferrucci L., et al. Metabolic factors associated with benign hyperplasia: the Baltimore Longitudinal Study of Aging. J Urol 175 suppl (2006) 432 abstract 1344
7. Chang S., Hypolite J.A., Changolkar A., Wein A.J., Chacko S., and DiSanto M.E. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Int J Impot Res 15 (2003) 53
8. Mills T.M., Chitaley K., Lewis R.W., and Webb R.C. Nitric oxide inhibits RhoA/Rho-kinase signaling to cause penile erection. Eur J Pharmacol 439 (2002) 173
9. Kaplan S.A., Meehan A.G., and Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?. J Urol 176 (2006) 1524
10. Kapoor D., Goodwin E., Channer K.S., and Jones T.H. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154 (2006) 899